Depo-Medrol warning tops OSN’s news of the week

Here are some of the top stories on Healio.com/OSN in the past week:
 
Remove Depo-Medrol from ophthalmological surgical suites to avoid accidental retinal toxicity
Methylprednisolone acetate, which has similar packaging and appearance to triamcinolone acetonide, should be removed from shelves of ophthalmological surgical suites because intraocular use can lead to irreversible retinal necrosis and permanent vision loss. Read more.
 
FDA places clinical hold on IND application for Adverum’s wet AMD gene therapy
The FDA has placed a clinical hold on Adverum Biotechnologies’

Full Story →